These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27301849)

  • 21. Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.
    Koen Talsma A; Shapiro J; Looman CW; van Hagen P; Steyerberg EW; van der Gaast A; van Berge Henegouwen MI; Wijnhoven BP; van Lanschot JJ; ; Hulshof MC; van Laarhoven HW; Nieuwenhuijzen GA; Hospers GA; Bonenkamp JJ; Cuesta MA; Blaisse RJ; Busch OR; ten Kate FJ; Creemers GJ; Punt CJ; Plukker JT; Verheul HM; van Dekken H; van der Sangen MJ; Rozema T; Biermann K; Beukema JC; Piet AH; van Rij CM; Reinders JG; Tilanus HW
    Ann Surg; 2014 Nov; 260(5):786-92; discussion 792-3. PubMed ID: 25379850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal analysis of cytokine expression during neoadjuvant chemoradiotherapy and subsequent surgery in esophageal cancer patients.
    Bosch DJ; Wang D; Nijsten MW; Mul VE; Hospers GA; Burgerhof JG; Struys MM; Plukker JT
    Am J Surg; 2016 Jul; 212(1):89-95. PubMed ID: 27036621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Quantified Scoring System for Postoperative Complication Severity Compared to the Clavien-Dindo Classification.
    Slaman AE; Lagarde SM; Gisbertz SS; van Berge Henegouwen MI
    Dig Surg; 2015; 32(5):361-6. PubMed ID: 26279268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical Outcome of Colon Interposition in Esophageal Cancer Surgery: Analysis of Risk Factors for Conduit-Related Morbidity.
    Lee K; Kim HR; Park SI; Kim DK; Kim YH; Choi SH
    Thorac Cardiovasc Surg; 2018 Aug; 66(5):384-389. PubMed ID: 28992653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
    Koëter M; van der Sangen MJ; Hurkmans CW; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
    Radiat Oncol; 2015 Mar; 10():59. PubMed ID: 25884226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative hyperbilirubinemia suggests the occurrence of complications after esophagectomy for esophageal cancer.
    Takesue T; Takeuchi H; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    World J Surg; 2015 May; 39(5):1111-8. PubMed ID: 25573838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.
    Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Klevebro F; Lindblad M; Ye W; Lundell L; Nilsson M
    Br J Surg; 2014 Mar; 101(4):321-38. PubMed ID: 24493117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of "Nil by Mouth" Versus Early Oral Intake in Three Different Diet Regimens Following Esophagectomy.
    Eberhard KE; Achiam MP; Rolff HC; Belmouhand M; Svendsen LB; Thorsteinsson M
    World J Surg; 2017 Jun; 41(6):1575-1583. PubMed ID: 28078353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.
    Lester SC; Lin SH; Chuong M; Bhooshan N; Liao Z; Arnett AL; James SE; Evans JD; Spears GM; Komaki R; Haddock MG; Mehta MP; Hallemeier CL; Merrell KW
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):820-828. PubMed ID: 28476435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study.
    Klevebro F; Elliott JA; Slaman A; Vermeulen BD; Kamiya S; Rosman C; Gisbertz SS; Boshier PR; Reynolds JV; Rouvelas I; Hanna GB; van Berge Henegouwen MI; Markar SR
    Ann Surg Oncol; 2019 Sep; 26(9):2864-2873. PubMed ID: 31183640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
    Elliott JA; O'Byrne L; Foley G; Murphy CF; Doyle SL; King S; Guinan EM; Ravi N; Reynolds JV
    Br J Surg; 2019 Sep; 106(10):1341-1351. PubMed ID: 31282584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thoracic versus cervical anastomosis on anastomotic leak among patients who undergo esophagectomy after neoadjuvant chemoradiation.
    Chidi AP; Etchill EW; Ha JS; Bush EL; Yang SC; Battafarano RJ; Broderick SR
    J Thorac Cardiovasc Surg; 2020 Oct; 160(4):1088-1095. PubMed ID: 32299695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.
    de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP
    Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70.
    Blom RL; van Heijl M; Klinkenbijl JH; Bergman JJ; Wilmink JW; Richel DJ; Hulshof MC; Reitsma JB; Busch OR; van Berge Henegouwen MI
    Dis Esophagus; 2013 Jul; 26(5):510-6. PubMed ID: 22925313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Investigation of Postoperative Complications in Patients With Gastroesophageal Junction Cancer Treated With Preoperative Chemotherapy or Surgery Alone.
    Achiam MP; Jensen LB; Larsson H; Jensen LS; Larsen AC; Holm J; Svendsen LB
    Scand J Surg; 2016 Mar; 105(1):22-8. PubMed ID: 25794689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus.
    Visser E; Edholm D; Smithers BM; Thomson IG; Burmeister BH; Walpole ET; Gotley DC; Joubert WL; Atkinson V; Mai T; Thomas JM; Barbour AP
    J Surg Oncol; 2018 Jun; 117(8):1687-1696. PubMed ID: 29806960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
    Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer.
    Tan JT; Yang Y; Mao NQ; Liu DS; Huang DM; Pan H; Xie T; Pan Q; Yang L; Zhong JH; Zuo CT
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27766708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma.
    Kathiravetpillai N; Koëter M; van der Sangen MJ; Creemers GJ; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2016 Aug; 42(8):1183-90. PubMed ID: 27134188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.